{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T00:33:00Z","timestamp":1709598780962},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,4]]},"DOI":"10.7759\/cureus.55486","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T14:22:45Z","timestamp":1709562165000},"source":"Crossref","is-referenced-by-count":0,"title":["Fluorodeoxyglucose (FDG) Uptake in the Remnant Adrenal Gland Mimicking Tumor Recurrence in a Patient With Adrenocortical Carcinoma After Treatment With Mitotane"],"prefix":"10.7759","author":[{"given":"Juan D","family":"Ayala Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Nore\u00f1a Rengifo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.01130","article-title":"Adrenocortical cancer: pathophysiology and clinical management","volume":"14","author":"Lib\u00e8 R","year":"2007","unstructured":"Lib\u00e8 R, Fratticci A, Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer. 2007, 14:13-28. 10.1677\/erc.1.01130","journal-title":"Endocr Relat Cancer"},{"key":"ref2","article-title":"High (18)F-FDG uptake by the remaining adrenal gland four months after surgery and initiation of mitotane treatment in two patients with adrenocortical carcinoma","volume":"14","author":"Mpanaka I","year":"2011","unstructured":"Mpanaka I, Lyra VD, Kaltsas G, Chatziioannou SN. High (18)F-FDG uptake by the remaining adrenal gland four months after surgery and initiation of mitotane treatment in two patients with adrenocortical carcinoma. Hell J Nucl Med. 2011, 14:168-72.","journal-title":"Hell J Nucl Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-011-0091-5","article-title":"FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma","volume":"2","author":"Deandreis D","year":"2011","unstructured":"Deandreis D, Leboulleux S, Caramella C, Schlumberger M, Baudin E. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma. Horm Cancer. 2011, 2:354-62. 10.1007\/s12672-011-0091-5","journal-title":"Horm Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0440-6","article-title":"Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography\/computed tomography: a review of literature","volume":"49","author":"Kandathil A","year":"2015","unstructured":"Kandathil A, Wong KK, Wale DJ, Zatelli MC, Maffione AM, Gross MD, Rubello D. Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography\/computed tomography: a review of literature. Endocrine. 2015, 49:6-26. 10.1007\/s12020-014-0440-6","journal-title":"Endocrine"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht M","year":"2009","unstructured":"Fassnacht M, Johanssen S, Quinkler M, et al.. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer. 2009, 115:243-50. 10.1002\/cncr.24030","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0666","article-title":"Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy","volume":"164","author":"Leboulleux S","year":"2011","unstructured":"Leboulleux S, Deandreis D, Escourrou C, et al.. Fluorodesoxyglucose uptake in the remaining adrenal glands during the follow-up of patients with adrenocortical carcinoma: do not consider it as malignancy. Eur J Endocrinol. 2011, 164:89-94. 10.1530\/EJE-10-0666","journal-title":"Eur J Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1575-0922(06)71132-9","article-title":"Therapeutic management of adrenocortical carcinoma","volume":"53","author":"Albero R","year":"2006","unstructured":"Albero R, Sanz A, Trincado P, Monreal M. Therapeutic management of adrenocortical carcinoma. Endocrinol y Nutr. 2006, 53:458-66. 10.1016\/S1575-0922(06)71132-9","journal-title":"Endocrinol y Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/234544-fluorodeoxyglucose-fdg-uptake-in-the-remnant-adrenal-gland-mimicking-tumor-recurrence-in-a-patient-with-adrenocortical-carcinoma-after-treatment-with-mitotane","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T14:22:47Z","timestamp":1709562167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/234544-fluorodeoxyglucose-fdg-uptake-in-the-remnant-adrenal-gland-mimicking-tumor-recurrence-in-a-patient-with-adrenocortical-carcinoma-after-treatment-with-mitotane"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.55486","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,4]]}}}